Trial Details
COMPLETEDBasic Information
| Clinical ID | c1592 |
|---|---|
| Identifier | NCT03327558 |
| Trial Title | Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Apriso 0.375G ER CAP|DRUG: APRISO 375 mg extended-release capsules |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | San Diego |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2017-05-15 |
|---|---|
| Primary Completion Date | 2017-06-23 |
| Completion Date | 2017-08-18 |